Financial report interval: 2025.12.31 - 2026.03.31
Preview: GeneDx(WGS) predict that the Revenue is 102.25 M (+17.38%), Miss estimate;the EBIT is -8.024 M (-207.7%), Miss estimate;the EPS is -2.16 (-839.1%), Miss estimate.